Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Utah Medical Products Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of UTMD: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders9289−3
Shares2.57M2.52M−53.1K (−2.1%)
Value$221.3M$211.9M−$9.43M (−4.3%)

New holders (7)

Institutions that held Utah Medical Products Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to UTMD in Q4 2023
InstitutionSharesValue% of portfolio
Bridge City Capital, LLC3,176$267.5K0.10%
EntryPoint Capital, LLC1,446$121.8K0.12%
Qube Research & Technologies Ltd1,013$85.3K0.00%
Northwest Financial Advisors300$25.3K0.02%
AJOVista, LLC233$19.6K0.02%
Private Wealth Management Group, LLC21$1.77K0.00%
GAMMA Investing LLC1$790.00%

Sold out (10)

Institutions that held Utah Medical Products Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of UTMD in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Natixis Advisors, L.P.12,811$1.10M
Man Group plc–$393.7K
O'Shaughnessy Asset Management, LLC3,542$304.6K
Invesco Ltd.2,718$233.7K
Panagora Asset Management Inc2,643$227.3K
Riverwater Partners LLC2,354$202.4K
Hillsdale Investment Management Inc.1,400$120.4K
Quadrant Capital Group LLC128$11.0K
Quantbot Technologies LP43$3.70K
Lindbrook Capital, LLC7$602